BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8824884)

  • 1. A candidate gene for mild mental handicap at the FRAXE fragile site.
    Chakrabarti L; Knight SJ; Flannery AV; Davies KE
    Hum Mol Genet; 1996 Feb; 5(2):275-82. PubMed ID: 8824884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom.
    Knight SJ; Ritchie RJ; Chakrabarti L; Cross G; Taylor GR; Mueller RF; Hurst J; Paterson J; Yates JR; Dow DJ; Davies KE
    Am J Hum Genet; 1996 May; 58(5):906-13. PubMed ID: 8651274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FRAXE mental retardation].
    Yamagata T
    Nihon Rinsho; 1999 Apr; 57(4):955-9. PubMed ID: 10222796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter.
    Ritchie RJ; Knight SJ; Hirst MC; Grewal PK; Bobrow M; Cross GS; Davies KE
    Hum Mol Genet; 1994 Dec; 3(12):2115-21. PubMed ID: 7881407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.
    Parrish JE; Oostra BA; Verkerk AJ; Richards CS; Reynolds J; Spikes AS; Shaffer LG; Nelson DL
    Nat Genet; 1994 Nov; 8(3):229-35. PubMed ID: 7874164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the gene FMR2, associated with FRAXE mental retardation.
    Gecz J; Gedeon AK; Sutherland GR; Mulley JC
    Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.
    Knight SJ; Flannery AV; Hirst MC; Campbell L; Christodoulou Z; Phelps SR; Pointon J; Middleton-Price HR; Barnicoat A; Pembrey ME
    Cell; 1993 Jul; 74(1):127-34. PubMed ID: 8334699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data.
    Hamel BC; Smits AP; de Graaff E; Smeets DF; Schoute F; Eussen BH; Knight SJ; Davies KE; Assman-Hulsmans CF; Oostra BA
    Am J Hum Genet; 1994 Nov; 55(5):923-31. PubMed ID: 7977354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of a new rare fragile site easily confused with the fragile X.
    Sutherland GR; Baker E
    Hum Mol Genet; 1992 May; 1(2):111-3. PubMed ID: 1301146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAXE expansion is not a common etiological factor among developmentally delayed males.
    Allingham-Hawkins DJ; Ray PN
    Am J Hum Genet; 1995 Jul; 57(1):72-6. PubMed ID: 7541938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island.
    Gu Y; Shen Y; Gibbs RA; Nelson DL
    Nat Genet; 1996 May; 13(1):109-13. PubMed ID: 8673086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chromosome fragility.
    Lukusa T; Fryns JP
    Biochim Biophys Acta; 2008 Jan; 1779(1):3-16. PubMed ID: 18078840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.
    Knight SJ; Voelckel MA; Hirst MC; Flannery AV; Moncla A; Davies KE
    Am J Hum Genet; 1994 Jul; 55(1):81-6. PubMed ID: 8023854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, cytogenetic, and molecular analysis of three families with FRAXE.
    Barnicoat AJ; Wang Q; Turk J; Green E; Mathew CG; Flynn G; Buckle V; Hirst M; Davies K; Bobrow M
    J Med Genet; 1997 Jan; 34(1):13-7. PubMed ID: 9032643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of FRAXE allele sizes in three populations.
    Zhong N; Ju W; Curley D; Wang D; Pietrofesa J; Wu G; Shen Y; Pang C; Poon P; Liu X; Gou S; Kajanoja E; Ryynänen M; Dobkin C; Brown WT
    Am J Med Genet; 1996 Aug; 64(2):415-9. PubMed ID: 8844095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.
    Flynn GA; Hirst MC; Knight SJ; Macpherson JN; Barber JC; Flannery AV; Davies KE; Buckle VJ
    J Med Genet; 1993 Feb; 30(2):97-100. PubMed ID: 8445629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of CGG region in FMR1 gene in mammals.
    Deelen W; Bakker C; Halley DJ; Oostra BA
    Am J Med Genet; 1994 Jul; 51(4):513-6. PubMed ID: 7943032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.
    Biancalana V; Taine L; Bouix JC; Finck S; Chauvin A; De Verneuil H; Knight SJ; Stoll C; Lacombe D; Mandel JL
    Am J Hum Genet; 1996 Oct; 59(4):847-54. PubMed ID: 8808600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
    Santos CB; Costa Lima MA; Pimentel MM
    Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE.
    Hirst MC; Barnicoat A; Flynn G; Wang Q; Daker M; Buckle VJ; Davies KE; Bobrow M
    Hum Mol Genet; 1993 Feb; 2(2):197-200. PubMed ID: 8499907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.